FdaApplication
ANDA 205217
Identifiers
- fda_app_no: ANDA205217
Properties
| Property | Value |
|---|---|
| applicant_name | LUPIN LTD |
| application_type | ANDA |
| approval_date | 2014-12-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMIVUDINE | LAMIVUDINE | 150MG | TABLET;ORAL |
| LAMIVUDINE | LAMIVUDINE | 300MG | TABLET;ORAL |
2 products